Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693718 · ClinicalTrials.gov registry record · Phase 2
A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT01693718 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 44 participants.
The verdict
NCT01693718, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.
Interventions
- DRUG Cisplatin
- DRUG Hydroxyurea
- DRUG 5- Fluorouracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2003-03 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693718
The ClinicalTrials.gov registry entry for NCT01693718 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cisplatin is the first listed.
NCT01693718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01693718 about?
NCT01693718 is a clinical study titled "A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer". The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.
What is the current status of trial NCT01693718?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2003-03. Estimated completion is 2004-09.
What interventions are being tested in trial NCT01693718?
The interventions under investigation include: Cisplatin (DRUG), Hydroxyurea (DRUG), 5- Fluorouracil (DRUG).
Who is sponsoring clinical trial NCT01693718?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.